IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19
Emanuel Della‐Torre, Elena Criscuolo, Marco Lanzillotta, Massimo Locatelli, Nicola Clementi, Nicasio Mancini, Lorenzo Dagna
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakAntibodyVirologyBetacoronavirusMedicineImmunologyInternal medicineOutbreakDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19